Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells
Crossref DOI link: https://doi.org/10.1007/s13577-017-0169-7
Published Online: 2017-04-05
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Osanai, Kiyono
Kobayashi, Yoichi http://orcid.org/0000-0002-8474-0625
Otsu, Masahiro
Izawa, Tomoko
Sakai, Keiji
Iwashita, Mitsutoshi
License valid from 2017-04-05